Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions, professional consulting, and auditing and coding services, which capture, aggregate, and translate structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which include an integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a coding analysis platform, as well as software services. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; Cerner Command Language (CCL) reporting; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

Wyche T. Green

Streamline Health Solutions, Inc.

Streamline Health Solutions, Inc. is a leader in pre-bill revenue integrity solutions for healthcare providers. Our eValuator™ Revenue Integrity Program includes integrated solutions, technology-enabled services and analytics that drive compliant revenue across the enterprise. We share a common calling and commitment to advance the quality of life and the quality of healthcare—for society, our clients, the communities they serve, and the individual patient. 

Comprehensive Partner for Revenue Integrity
With technology and services exclusively focused on the middle of the revenue cycle, Streamline Health is leading an industry movement to help providers confirm coding accuracy and revenue integrity prior to billing. By bundling our cloud-based solutions and technology-enabled services in flexible packages, we enable providers to choose the best combination of technology and support to drive pre-bill revenue integrity and improve financial performance across their organizations.

Streamline Health

We are hiring for a Business Analyst -- Meet the requirements for the position? We want to talk to you! See more and apply below:

https://bit.ly/41JRSYG

#BusinessAnalyst #Healthcare #FinTech #HealthTech

We are proudly among the Becker's Healthcare 274 #RevCycle companies to know in 2023. There are many #RevenueCycle facets and we are proud to be a leading provider of optimization solutions and technology-enabled services.
https://bit.ly/3lY31oa
#FinTech #HealthTech

Insightful feedback from our own Kevin Martinek consolidating the recent Crowe #revcycle benchmarking report ⬇ 

------

Great report released by our friends at Crowe, outlining KPI benchmark data for denials from 2021 through November 2022. Several key takeaways based on what they share:

- CMS monthly enrollment reports show Medicare Advantage (MA) enrollment steadily growing
- Jan. 2021 to Jan. 2022 they grew from 26.6M to 29M – 9% increase
- Jan. 2022 to Jan. 2023 they grew from 29M to 30.8M – 6.1% increase
- Jan. 2023 to Feb. 2023 they grew from 30.8M to 31.4M – 2.2% increase
- Value of initial clinical denials represented 4.2% of billed inpatient dollars – up 18.5% from 2021
- Higher denial rates for MA plans compared to other payor categories – 5.8% vs. 3.7%
- Inpatient revenue write-offs were at 5.9% vs. 3.6% in 2021 – 64% increase
- Isolating the MA plan population, write-offs were at 8.5% vs. 4.7% in 2021 – 81% increase

The report also summarizes some key areas providers can focus on to improve NET revenue performance. With the capitated model of MA plans and enrollments continuing to increase, the recent CMS RADV rule change is likely to further fuel the upward denial trend. Deploying strategies to ensure patient charts accurately reflect medical necessity and are coded correctly, prior to claim submission, will become increasingly important preventative measures to take in 2023 and the years ahead.

CMS monthly enrollment reports – https://lnkd.in/gHdGNp26

#fintech #healthtech #revenuecyclemanagement #revenuecyclemanagement

We are hiring for a System Engineer -- Meet the requirements for the position? We want to talk to you! See more and apply below:

https://bit.ly/3kdFvmP

#SystemEngineer #Healthcare #FinTech #HealthTech

Beau is continuing to work his way through Texas networking with #HFMA thought leaders and professionals in the Houston area! Take a look at how to connect with him here: https://bit.ly/3S3sOam

HFMA Texas Gulf Coast Chapter

Nothing like a February #HFMA double header in Texas featuring Beau Benson -- Want to connect with Beau while he is at the #TexasHFMA Gulf Coast or Lone Star Winter Conferences? Visit https://bit.ly/3lEIyVh to see Beau's contact info, see an overview of our solutions, and grab Starbucks on us!

HFMA Texas Gulf Coast Chapter // HFMA South Texas Chapter 
#FinTech #HealthTech #RevenueCycle #RevenueCycleManagement

We are hiring for a Project Analyst and Coordinator Role -- Meet the requirements for the position? We want to talk to you! See more and apply below:
https://bit.ly/3xp9jQ4

#FinTech #HealthTech #RevenueCycleManagement

Great to see our own Amy Sebero and her friends connecting at #SES023. Visit us in Booth 10 to hear the latest in revenue integrity tools and best practices!

#fintech #healthtech #healthcare #revenuecyclemanagement

So excited to see everyone at #SES2023 in Midtown Atlanta! Visit us in Booth 10 for free Starbucks gift cards and learn how to proactively improve financial performance from Amy Sebero, Ashley Lodato, Stella Street and David Mayr. To learn more now, visit https://bit.ly/3RJC17E

#fintech #healthtech #healthcare #revenuecyclemanagement

#Fintech conversation, #healthtech solutions, and Starbucks all await you at Booth #10 this coming week at #SES2023. To schedule a meeting with us, or get a jump start on claiming our in booth goods, visit https://bit.ly/3RJC17E. #revenuecycle #revenuecyclemanagement

HFMA Region 5 South Eastern Summit 2023

Metric
Company Name	Streamline Health Solutions, Inc.
Symbol	STRM
MSH ID	NET:STREAMLINEHEALTH
Market	STOCKS
Sector	Healthcare
Industry	Medical - Healthcare Information Services
Country	US
Stage
Employee Count	77
Website	streamlinehealth.net
LinkedIn	streamline-health
Founders

Metric
Market Cap	31.02M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	22.60M
Revenue (LTM)
Revenue (NTM)
Gross Profit	11.54M
EBITDA	-18.65M
Operating Income	-18.65M
Net Income	-18.70M
EPS	-0.33
Diluted EPS	-0.33
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	1.00
Operating Profit Margin	-0.63
EBITDA Margin	-0.83
Net Profit Margin	-0.63
Return on Equity	-0.63
Return on Assets	-0.07
Return on Capital Employed	-0.10

NET:STREAMLINEHEALTH

Streamline Health Solutions, LLC

Last Close

3.02

22/11 21:00

Market Cap

31.02M

Beta: -

Volume Today

16.76K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-1.10
P/B Ratio	1.09
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	8.02
EV Multiple	0.82

Metric
Days Sales Outstanding	67.22
Days Payables Outstanding	22.34
Days Inventory Outstanding
Operating Cycle	395.12
Cash Conversion Cycle	45.71
Asset Turnover	0.58

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt	-0.00
Operating Cash Flow/Sales	-0.00
Free Cash Flow Yield	-0.30

Metric
Cash & Equivalents	3.19B
Accounts Receivable
Inventory
Goodwill	13.28B
Debt to Capitalization	0.44
Debt to Assets	0.24
Current Ratio	0.61
Quick Ratio	0.76

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.09
R&D to Revenue	0.24
SG&A to Revenue	88.31